Production and Characterization of Two Specific ZIKV Antigens Based on Bioinformatic Analysis and Serological Screening

References

• Agarwal A, Chaurasia D. 2021. The expanding arms of Zika virus: an updated review with recent Indian outbreaks. Rev Med Virol. 31(1):1–9.
   PubMed Web of Science ®Google Scholar
• Akhras S, Herrlein M-L, Elgner F, Holzhauser T, Hildt E. 2019. ZIKV envelope domain-specific antibodies: production, purification and characterization. Viruses. 11(8):748.
   PubMed Web of Science ®Google Scholar
• Amrun SN, Yee WX, Abu Bakar F, Lee B, Kam YW, Lum FM, Tan JJ, Lim VW, Watthanaworawit W, Ling C. 2019. Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients. Clin Transl Immunol. 8(7):e1066. doi:10.1002/cti2.1066.
   PubMed Web of Science ®Google Scholar
• Bush GL, Tassin AM, Fridén H, Meyer DI. 1991. Secretion in Yeast: purification and in vitro translocation of chemical amounts of prepro-a-factor. J Biol Chem. 266(21):13811–14.
   PubMed Web of Science ®Google Scholar
• Campos GS, Bandeira AC, Sardi SI. 2015. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis. 21(10):1885–86.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu H, Yang J, Chou K-C. 2007. Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids. 33(3):423–28.
   PubMed Web of Science ®Google Scholar
• El-Manzalawy Y, Dobbs D, Honavar V. 2008. Predicting flexible length linear B-cell epitopes. Comput Syst Bioinf. 7:121.
   PubMedGoogle Scholar
• Felix AC, Souza NCS, Figueiredo WM, Costa AA, Inenami M, da Silva RMG, Levi JE, Pannuti CS, Romano CM. 2017. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol. 89(8):1477–79.
   PubMed Web of Science ®Google Scholar
• Fumagalli MJ, Figueiredo LT, Aquino VH. 2021. Linear and continuous flavivirus epitopes from naturally infected humans. Front Cell Infect Microbiol. 11. doi:10.3389/fcimb.2021.710551.
   PubMed Web of Science ®Google Scholar
• Hebditch M, Carballo-Amador MA, Charonis S, Curtis R, Warwicker J, et al. 2017. Protein–sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 33(19):3098.
   PubMed Web of Science ®Google Scholar
• Hochuli E. 1990. Purification of recombinant proteins with metal chelate adsorbent. Genet Eng (N Y). 12:87–98.
   PubMedGoogle Scholar
• Lee AJ, Bhattacharya R, Scheuermann RH, Pickett BE. 2017. Identification of diagnostic peptide regions that distinguish Zika virus from related mosquito-borne Flaviviruses. PLoS One. 12(5):e0178199.
   PubMed Web of Science ®Google Scholar
• Mcnamara LA, Martin SW. 2018. Principles of epidemiology and public health. Princ Pract Pediatr Infect Dis. 1–9.e1.
   Google Scholar
• Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, et al. 2016. Zika virus associated with microcephaly. N Engl J Med. 374(10):951–58.
   PubMed Web of Science ®Google Scholar
• Muller DA, Young PR. 2013. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. 98(2):192–208. doi:10.1016/j.antiviral.2013.03.008.
   Google Scholar
• Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg LC, Panda AK. 2000. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr Purif. 18(2):182–92.
   PubMed Web of Science ®Google Scholar
• Ponomarenko JV, Bourne PE. 2007. Antibody-protein interactions: benchmark datasets and prediction tools evaluation. BMC Struct Biol. 7(1):1–19.
   PubMedGoogle Scholar
• Rawal G, Yadav S, Kumar R. 2016. Zika virus: an overview. J Fam Med Primary Care. 5(3):523.
   PubMedGoogle Scholar
• Rodriguez-Barraquer I, Costa F, Nascimento EJM, Nery N, Castanha PMS, Sacramento GA, Cruz J, Carvalho M, De Olivera D, Hagan JE et al. 2019. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 363(6427):607–10. doi:10.1126/science.aav6618.
   PubMed Web of Science ®Google Scholar
• Rogers TF, Goodwin EC, Briney B, Sok D, Beutler N, Strubel A, Nedellec R, Le K, Brown ME, Burton DR et al, , Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Science Immunology. 2017 Aug 18; 2(14):eaan6809. doi: 10.1126/sciimmunol.aan6809.
   PubMed Web of Science ®Google Scholar
• Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, Bartenschlager R et al. 2015. Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins. PLoS Pathog. 11(11). 10.1371/journal.ppat.1005277
   PubMed Web of Science ®Google Scholar
• Schuler-Faccini L, Ribeiro EM, Feitosa IML, Horovitz DDG, Cavalcanti DP, Pessoa A, Doriqui MJR, Neri JI, Neto JMDP, Wanderley HYC, et al. 2019. Possible association between Zika virus infection and microcephaly — Brazil, 2015. MMWR Morb Mortal Wkly Rep. 65(3):59–62.
   Google Scholar
• Sornjai W, Ramphan S, Wikan N, Auewarakul P, Smith DR. 2019. High correlation between Zika virus NS1 antibodies and neutralizing antibodies in selected serum samples from normal healthy Thais. Sci Rep. 9(1):1–10.
   PubMedGoogle Scholar
• Wen J, Shresta S. 2019. Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?. Curr Opin Immunol. Aug;59:1–8. doi: 10.1016/j.coi.2019.02.001. Epub Mar 15.
   PubMed Web of Science ®Google Scholar
• Yap TL, Hong SY, Soh JH, Ravichandraprabhu L, Lim VWX, Chan H-M, Ong TZX, Chua YP, Koh SE, Wang H, et al. 2021. Engineered NS1 for sensitive, specific Zika virus diagnosis from patient serology. Emerg Infect Dis. 27(5):1427–37.
   PubMed Web of Science ®Google Scholar
• Zhang H, Qian P, Liu L, Qian S, Chen H, Li X. 2014. Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes. Viruses. 6:4839–55.
   PubMed Web of Science ®Google Scholar